These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 31519175)

  • 1. The endotoxin hypothesis of neurodegeneration.
    Brown GC
    J Neuroinflammation; 2019 Sep; 16(1):180. PubMed ID: 31519175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Endotoxin Hypothesis of Parkinson's Disease.
    Brown GC; Camacho M; Williams-Gray CH
    Mov Disord; 2023 Jul; 38(7):1143-1155. PubMed ID: 37157885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endotoxin hypothesis of Alzheimer's disease.
    Brown GC; Heneka MT
    Mol Neurodegener; 2024 Apr; 19(1):30. PubMed ID: 38561809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of endotoxin tolerance on peripheral lipopolysaccharide-induced neuroinflammation and dopaminergic neuronal injury.
    Yao L; Li P; Chen Q; Hu A; Wu Y; Li B
    Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):326-337. PubMed ID: 35260024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y
    Milde S; van Tartwijk FW; Vilalta A; Hornik TC; Dundee JM; Puigdellívol M; Brown GC
    J Neuroinflammation; 2021 Oct; 18(1):225. PubMed ID: 34635136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice.
    Szego EM; Malz L; Bernhardt N; Rösen-Wolff A; Falkenburger BH; Luksch H
    Elife; 2022 Oct; 11():. PubMed ID: 36314770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial pathogens induce neurodegeneration in Alzheimer's disease mice: protection by microglial regulation.
    Ganz T; Fainstein N; Elad A; Lachish M; Goldfarb S; Einstein O; Ben-Hur T
    J Neuroinflammation; 2022 Jan; 19(1):5. PubMed ID: 34991645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
    Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS
    Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma.
    Ramirez AI; de Hoz R; Salobrar-Garcia E; Salazar JJ; Rojas B; Ajoy D; López-Cuenca I; Rojas P; Triviño A; Ramírez JM
    Front Aging Neurosci; 2017; 9():214. PubMed ID: 28729832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial phagocytosis of neurons in neurodegeneration, and its regulation.
    Butler CA; Popescu AS; Kitchener EJA; Allendorf DH; Puigdellívol M; Brown GC
    J Neurochem; 2021 Aug; 158(3):621-639. PubMed ID: 33608912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role of NLRP3-generated IL-1β in the acute-chronic transition of peripheral lipopolysaccharide-elicited neuroinflammation: implications for sepsis-associated neurodegeneration.
    Zhao Z; Wang Y; Zhou R; Li Y; Gao Y; Tu D; Wilson B; Song S; Feng J; Hong JS; Yakel JL
    J Neuroinflammation; 2020 Feb; 17(1):64. PubMed ID: 32070376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
    Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
    FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration.
    Cunningham C; Wilcockson DC; Campion S; Lunnon K; Perry VH
    J Neurosci; 2005 Oct; 25(40):9275-84. PubMed ID: 16207887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease.
    George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P
    Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration.
    Tu D; Gao Y; Yang R; Guan T; Hong JS; Gao HM
    J Neuroinflammation; 2019 Dec; 16(1):255. PubMed ID: 31805953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
    Liu Y; Qin L; Li G; Zhang W; An L; Liu B; Hong JS
    J Pharmacol Exp Ther; 2003 Apr; 305(1):212-8. PubMed ID: 12649371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models.
    Wang Q; Qian L; Chen SH; Chu CH; Wilson B; Oyarzabal E; Ali S; Robinson B; Rao D; Hong JS
    Brain; 2015 May; 138(Pt 5):1247-62. PubMed ID: 25716193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.